Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00633438 · ClinicalTrials.gov registry record · Phase 4
Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery
A Phase 4 study of Arthroscopy, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- Completed
- Registry status
- Phase 4
- Development phase
- 204
- Enrollment target
- 18
- Study locations
NCT00633438: Completed Phase 4 study of Arthroscopy, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
NCT00633438 is a Phase 4 study of Arthroscopy that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 204 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower). The trial reports 18 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00633438, a Phase 4 study of Arthroscopy, has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 204 participants
- Enrollment target
- 18
- Study locations
Study Summary
To compare total analgesic use at 24 hours after arthroscopic knee surgery in celecoxib-treated versus placebo-treated patients
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Celecoxib
Study Locations (18)
Massachusetts
- Pfizer Investigational Site - Springfield
- Pfizer Investigational Site - Springfield
- Pfizer Investigational Site - Springfield
- Pfizer Investigational Site - Springfield
South Carolina
- Pfizer Investigational Site - Columbia
- Pfizer Investigational Site - Columbia
- Pfizer Investigational Site - Columbia
- Pfizer Investigational Site - Orangeburg
Texas
- Pfizer Investigational Site - San Antonio
- Pfizer Investigational Site - San Antonio
- Pfizer Investigational Site - San Antonio
- Pfizer Investigational Site - San Antonio
Maryland
- Pfizer Investigational Site - Baltimore
- Pfizer Investigational Site - Timonium
Arizona
- Pfizer Investigational Site - Phoenix
Florida
- Pfizer Investigational Site - St. Petersburg
Missouri
- Pfizer Investigational Site - Springfield
Tennessee
- Pfizer Investigational Site - Johnson City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2004-01 |
| Est. Completion | 2004-06 |
| Phase | Phase 4 |
What the finished NCT00633438 record still lists
NCT00633438 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Arthroscopy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00633438 lists 18 locations in 8 states (Massachusetts, South Carolina, Texas).
Frequently Asked Questions
What is clinical trial NCT00633438 about?
NCT00633438 is a clinical study titled "Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery". To compare total analgesic use at 24 hours after arthroscopic knee surgery in celecoxib-treated versus placebo-treated patients
What is the current status of trial NCT00633438?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 204 participants. The study started on 2004-01. Estimated completion is 2004-06.
What conditions does trial NCT00633438 study?
This clinical trial studies the following conditions: Arthroscopy.
What interventions are being tested in trial NCT00633438?
The interventions under investigation include: Placebo (OTHER), Celecoxib (DRUG).
Who is sponsoring clinical trial NCT00633438?
This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00633438 being conducted?
This trial has 18 study locations across Arizona, Florida, Maryland, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00633438's enrollment target sits among peer trials
204 402nd of 2000 higher than 1,598 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia